AAAAAA

   
Results: 1-25 | 26-50 | 51-75 | 76-100 | >>
Results: 51-75/116
TREATMENT OF SEVERE FAMILIAL HYPERTRIGLYCERIDEMIA DURING PREGNANCY WITH VERY-LOW-FAT DIET AND N-3 FATTY-ACIDS
Authors: GLUECK CJ STREICHER P WANG P SPRECHER D FALKO JM
Citation: Cj. Glueck et al., TREATMENT OF SEVERE FAMILIAL HYPERTRIGLYCERIDEMIA DURING PREGNANCY WITH VERY-LOW-FAT DIET AND N-3 FATTY-ACIDS, Nutrition, 12(3), 1996, pp. 202-205
REVERSIBLE PAROTID ENLARGEMENT AND PSEUDO-SJOGRENS SYNDROME SECONDARYTO HYPERTRIGLYCERIDEMIA
Authors: SHEIKH JS SHARMA M KUNATH A FRITZ DA GLUECK CJ HESS EV
Citation: Js. Sheikh et al., REVERSIBLE PAROTID ENLARGEMENT AND PSEUDO-SJOGRENS SYNDROME SECONDARYTO HYPERTRIGLYCERIDEMIA, Journal of rheumatology, 23(7), 1996, pp. 1288-1291
RISK-FACTORS FOR CORONARY HEART-DISEASE AMONG FIREFIGHTERS IN CINCINNATI
Authors: GLUECK CJ KELLEY W WANG P GARTSIDE PS BLACK D TRACY T
Citation: Cj. Glueck et al., RISK-FACTORS FOR CORONARY HEART-DISEASE AMONG FIREFIGHTERS IN CINCINNATI, American journal of industrial medicine, 30(3), 1996, pp. 331-340
MEASUREMENT OF LIPOPROTEIN(A) - COMPARISON OF MACRA(TM) AND IMUBIND(R) METHODS
Authors: STROOP DM GLUECK CJ MCCRAY C SPEIRS J SCHUMACHER HR
Citation: Dm. Stroop et al., MEASUREMENT OF LIPOPROTEIN(A) - COMPARISON OF MACRA(TM) AND IMUBIND(R) METHODS, Annals of clinical and laboratory science, 26(4), 1996, pp. 329-339
THE PATHOPHYSIOLOGY OF ALVEOLAR OSTEONECROSIS OF THE JAW - ANTICARDIOLIPIN ANTIBODIES, THROMBOPHILIA, AND HYPOFIBRINOLYSIS
Authors: GRUPPO R GLUECK CJ MCMAHON RE BOUQUOT J RABINOVICH BA BECKER A TRACY T WANG P
Citation: R. Gruppo et al., THE PATHOPHYSIOLOGY OF ALVEOLAR OSTEONECROSIS OF THE JAW - ANTICARDIOLIPIN ANTIBODIES, THROMBOPHILIA, AND HYPOFIBRINOLYSIS, The Journal of laboratory and clinical medicine, 127(5), 1996, pp. 481-488
ASSOCIATION OF ANTITHROMBOTIC FACTOR DEFICIENCIES AND HYPOFIBRINOLYSIS WITH LEGG-PERTHES DISEASE
Authors: GLUECK CJ CRAWFORD A ROY D FREIBERG R GLUECK H STROOP D
Citation: Cj. Glueck et al., ASSOCIATION OF ANTITHROMBOTIC FACTOR DEFICIENCIES AND HYPOFIBRINOLYSIS WITH LEGG-PERTHES DISEASE, Journal of bone and joint surgery. American volume, 78A(1), 1996, pp. 3-13
MYOPATHY ASSOCIATED WITH LIPID-LOWERING THERAPY IN PATIENTS WITH PREVIOUSLY UNDIAGNOSED OR UNDERTREATED HYPOTHYROIDISM
Authors: LANG JE WANG P GLUECK CJ
Citation: Je. Lang et al., MYOPATHY ASSOCIATED WITH LIPID-LOWERING THERAPY IN PATIENTS WITH PREVIOUSLY UNDIAGNOSED OR UNDERTREATED HYPOTHYROIDISM, Clinica chimica acta, 254(1), 1996, pp. 85-92
THE IMPORTANT ROLE OF MODIFIABLE DIETARY-CHARACTERISTICS AND BEHAVIORAL-CHARACTERISTICS IN THE CAUSATION AND PREVENTION OF CORONARY-HEART-DISEASE HOSPITALIZATION AND MORTALITY - THE PROSPECTIVE NHANES-I FOLLOW-UP-STUDY
Authors: GARTSIDE PS GLUECK CJ
Citation: Ps. Gartside et Cj. Glueck, THE IMPORTANT ROLE OF MODIFIABLE DIETARY-CHARACTERISTICS AND BEHAVIORAL-CHARACTERISTICS IN THE CAUSATION AND PREVENTION OF CORONARY-HEART-DISEASE HOSPITALIZATION AND MORTALITY - THE PROSPECTIVE NHANES-I FOLLOW-UP-STUDY, Journal of the American College of Nutrition, 14(1), 1995, pp. 71-79
IDIOPATHIC OSTEONECROSIS, HYPOFIBRINOLYSIS, HIGH PLASMINOGEN-ACTIVATOR INHIBITOR, HIGH LIPOPROTEIN(A), AND THERAPY WITH STANOZOLOL
Authors: GLUECK CJ FREIBERG R GLUECK HI TRACY T STROOP D WANG Y
Citation: Cj. Glueck et al., IDIOPATHIC OSTEONECROSIS, HYPOFIBRINOLYSIS, HIGH PLASMINOGEN-ACTIVATOR INHIBITOR, HIGH LIPOPROTEIN(A), AND THERAPY WITH STANOZOLOL, American journal of hematology, 48(4), 1995, pp. 213-220
THROMBOPHILIA (RESISTANCE TO ACTIVATED PROTEIN-C, LOW PROTEIN-C OR PROTEIN-S) AND HYPOFIBRINOLYSIS CAUSING LEGG-PERTHES-DISEASE
Authors: GLUECK CJ BRANDT G GRUPPO R CRAWFORD A ROY D BECKER A TRACY T STROOP D
Citation: Cj. Glueck et al., THROMBOPHILIA (RESISTANCE TO ACTIVATED PROTEIN-C, LOW PROTEIN-C OR PROTEIN-S) AND HYPOFIBRINOLYSIS CAUSING LEGG-PERTHES-DISEASE, Thrombosis and haemostasis, 73(6), 1995, pp. 1362-1362
FAMILIAL RESISTANCE TO ACTIVATED PROTEIN-C CAUSING LEGG-PERTHES DISEASE
Authors: GLUECK CJ BRANDT G GRUPPO R CRAWFORD A ROY D BECKER A TRACY T STROOP D
Citation: Cj. Glueck et al., FAMILIAL RESISTANCE TO ACTIVATED PROTEIN-C CAUSING LEGG-PERTHES DISEASE, Thrombosis and haemostasis, 73(6), 1995, pp. 1367-1367
THROMBOPHILIA (RESISTANCE TO ACTIVATED PROTEIN-C, LOW-PROTEIN C OR S)AND HYPOFIBRINOLYSIS CAUSING LEGG-PERTHES DISEASE
Authors: GLUECK CJ BRANDT G GUPPO R CRAWFORD A ROY D BECKER A TRACY T STOOP D
Citation: Cj. Glueck et al., THROMBOPHILIA (RESISTANCE TO ACTIVATED PROTEIN-C, LOW-PROTEIN C OR S)AND HYPOFIBRINOLYSIS CAUSING LEGG-PERTHES DISEASE, Pediatric research, 37(4), 1995, pp. 157-157
FAMILIAL RESISTANCE TO ACTIVATED PROTEIN-C CAUSING LEGG-PERTHES DISEASE
Authors: GLUECK CJ BRANDT G GRUPPO R CRAWFORD A ROY D BECKER A TRACY T STROOP D
Citation: Cj. Glueck et al., FAMILIAL RESISTANCE TO ACTIVATED PROTEIN-C CAUSING LEGG-PERTHES DISEASE, Pediatric research, 37(4), 1995, pp. 157-157
HYPOFIBRINOLYTIC AND ATHEROGENIC RISK-FACTORS FOR STROKE
Authors: GLUECK CJ RORICK MH SCHMERLER M ANTHONY J FEIBEL J BASHIR M GLUECK HI STROOP D WANG Y TRACY TM
Citation: Cj. Glueck et al., HYPOFIBRINOLYTIC AND ATHEROGENIC RISK-FACTORS FOR STROKE, The Journal of laboratory and clinical medicine, 125(3), 1995, pp. 319-325
WHETHER, TO WHAT DEGREE, AND WHY LIPOPROTEIN(A) LEVELS CHANGE OVER TIME
Authors: GLUECK CJ TRACY T SIEVESMITH L WANG P
Citation: Cj. Glueck et al., WHETHER, TO WHAT DEGREE, AND WHY LIPOPROTEIN(A) LEVELS CHANGE OVER TIME, Clinica chimica acta, 238(1), 1995, pp. 11-19
RESISTANCE TO ACTIVATED PROTEIN-C AND LEGG-PERTHES DISEASE
Authors: GLUECK CJ BRANDT G GRUPPO R CRAWFORD A ROY D BECKER A TRACY T STROOP D WANG P
Citation: Cj. Glueck et al., RESISTANCE TO ACTIVATED PROTEIN-C AND LEGG-PERTHES DISEASE, Circulation, 92(8), 1995, pp. 2990-2990
TREATMENT OF HOMOCYSTEINEMIA WITH FOLIC-ACID, PYRIDOXINE, AND VITAMIN-B12
Authors: GLUECK CJ LANG JE TRACY T SIEVESMITH L WANG Y WANG P
Citation: Cj. Glueck et al., TREATMENT OF HOMOCYSTEINEMIA WITH FOLIC-ACID, PYRIDOXINE, AND VITAMIN-B12, The American journal of clinical nutrition, 61(4), 1995, pp. 910-910
EVIDENCE THAT HOMOCYSTEINE IS AN INDEPENDENT RISK FACTOR FOR ATHEROSCLEROSIS IN HYPERLIPIDEMIC PATIENTS
Authors: GLUECK CJ SHAW P LANG JE TRACY T SIEVESMITH L WANG Y
Citation: Cj. Glueck et al., EVIDENCE THAT HOMOCYSTEINE IS AN INDEPENDENT RISK FACTOR FOR ATHEROSCLEROSIS IN HYPERLIPIDEMIC PATIENTS, The American journal of cardiology, 75(2), 1995, pp. 132-136
MEASUREMENT OF PLASMINOGEN-ACTIVATOR INHIBITOR TYPE-1 ANTIGEN - COMPARISON OF TINTELIZE(TM) AND IMUBIND(TM) METHODS
Authors: STROOP DM GLUECK CJ TRACY TM SCHUMACHER HR
Citation: Dm. Stroop et al., MEASUREMENT OF PLASMINOGEN-ACTIVATOR INHIBITOR TYPE-1 ANTIGEN - COMPARISON OF TINTELIZE(TM) AND IMUBIND(TM) METHODS, Blood coagulation & fibrinolysis, 5(6), 1994, pp. 865-872
HYPOFIBRINOLYSIS - A COMMON, MAJOR CAUSE OF OSTEONECROSIS
Authors: GLUECK CJ FREIBERG R GLUECK HI HENDERSON C WELCH M TRACY T STROOP D HAMER T SOSA F LEVY M
Citation: Cj. Glueck et al., HYPOFIBRINOLYSIS - A COMMON, MAJOR CAUSE OF OSTEONECROSIS, American journal of hematology, 45(2), 1994, pp. 156-166
FAMILIAL IDIOPATHIC OSTEONECROSIS MEDIATED BY FAMILIAL HYPOFIBRINOLYSIS WITH HIGH-LEVELS OF PLASMINOGEN-ACTIVATOR INHIBITOR
Authors: GLUECK CJ GLUECK HI WELCH M FREIBERG R TRACY T HAMER T STROOP D
Citation: Cj. Glueck et al., FAMILIAL IDIOPATHIC OSTEONECROSIS MEDIATED BY FAMILIAL HYPOFIBRINOLYSIS WITH HIGH-LEVELS OF PLASMINOGEN-ACTIVATOR INHIBITOR, Thrombosis and haemostasis, 71(2), 1994, pp. 195-198
DIETARY-FAT SUBSTITUTES
Authors: GLUECK CJ STREICHER PA ILLIG EK WEBER KD
Citation: Cj. Glueck et al., DIETARY-FAT SUBSTITUTES, Nutrition research, 14(10), 1994, pp. 1605-1619
HYPOCHOLESTEROLEMIA, HYPERTRIGLYCERIDEMIA, SUICIDE, AND SUICIDE IDEATION IN CHILDREN HOSPITALIZED FOR PSYCHIATRIC DISEASES
Authors: GLUECK CJ KULLER FE HAMER T RODRIGUEZ R SOSA F SIEVESMITH L MORRISON JA
Citation: Cj. Glueck et al., HYPOCHOLESTEROLEMIA, HYPERTRIGLYCERIDEMIA, SUICIDE, AND SUICIDE IDEATION IN CHILDREN HOSPITALIZED FOR PSYCHIATRIC DISEASES, Pediatric research, 35(5), 1994, pp. 602-610
PROTEIN-C AND PROTEIN-S DEFICIENCY, THROMBOPHILIA, AND HYPOFIBRINOLYSIS - PATHOPHYSIOLOGIC CAUSES OF LEGG-PERTHES DISEASE
Authors: GLUECK CJ GLUECK HI GREENFIELD D FREIBERG R KAHN A HAMER T STROOP D TRACY T
Citation: Cj. Glueck et al., PROTEIN-C AND PROTEIN-S DEFICIENCY, THROMBOPHILIA, AND HYPOFIBRINOLYSIS - PATHOPHYSIOLOGIC CAUSES OF LEGG-PERTHES DISEASE, Pediatric research, 35(4), 1994, pp. 383-388
METFORMIN THERAPY IN POLYCYSTIC-OVARY-SYNDROME REDUCES HYPERINSULINEMIA, INSULIN-RESISTANCE, HYPERANDROGENEMIA, AND SYSTOLIC BLOOD-PRESSURE, WHILE FACILITATING NORMAL MENSES AND PREGNANCY
Authors: VELAZQUEZ EM MENDOZA S HAMER T SOSA F GLUECK CJ
Citation: Em. Velazquez et al., METFORMIN THERAPY IN POLYCYSTIC-OVARY-SYNDROME REDUCES HYPERINSULINEMIA, INSULIN-RESISTANCE, HYPERANDROGENEMIA, AND SYSTOLIC BLOOD-PRESSURE, WHILE FACILITATING NORMAL MENSES AND PREGNANCY, Metabolism, clinical and experimental, 43(5), 1994, pp. 647-654
Risultati: 1-25 | 26-50 | 51-75 | 76-100 | >>